ProMIS Neurosciences to present preclinical data on computationally-derived vaccines for neurodegenerative diseases at AAN 2025
ProMIS Neurosciences Inc. a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s… read more.